Latest News and Press Releases

~ Strong commercial momentum underpins transformative financial performance ~ Strong 2024 financial performance in line with guidance Revenue growth of 44% to £128.8 million compared to 2023,...

Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219 SYX-5219 is a first-in-class oral PKM2 modulator designed to drive sustained disease...

EBC and University of Oxford’s WERD Series panel explores global economic growth and climate resilience, spotlighting the role of policies and finance.

EBC and University of Oxford explore macroeconomic policies for climate resilience and sustainable growth in the WERD 2024-25 webinar series.

Lahore, Pakistan, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Following the “National Dialogue on Pakistan’s Permacrisis” event held yesterday at the Governor House Lahore, Oxford Alumni Pakistan announced...

London, United Kingdom, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Renowned policy advocacy group Beltway Grid has analyzed the recent Legal Opinion by the prestigious King’s Counsel Hugh Southey of the...

Lord Cameron will lead international efforts to drive the OHC’s mission of delivering 40 new therapies for rare diseases into clinical trials over the next ten years OXFORD, UK and CLEVELAND,...

PRESS RELEASE OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024 Oxford, United Kingdom – 5th August 2024 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology...

Vela Partners & The University of Oxford publish research on a new LLM and AI agent that make investment decisions 100x cheaper and 5x faster than humans.

OrganOx Appoints Stephen M. Deitsch, an experienced medtech finance leader with proven track record with IPOs, as new Chief Financial Officer.